MASSACHUSETTS GENERAL HOSPITAL
Genetics, glycemic control and the microbiome in cystic fibrosis
Genetics, glycemic control and the microbiome in cystic fibrosis is a funding opportunity from MASSACHUSETTS GENERAL HOSPITAL, up to 199745, closing June 30, 2027.
Jun 30, 2027
(334d left)Overview
Cystic fibrosis related diabetes (CFRD) is the most common non-pulmonary complication of cystic fibrosis (CF), affecting up to 50% of adults. This diagnosis is linked to more pulmonary exacerbations, worsening lung function, and increased mortality compared to those without CFRD. Individuals with CFRD have more…